236 related articles for article (PubMed ID: 16458994)
1. Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy.
Vallejo M; Briz O; Serrano MA; Monte MJ; Marin JJ
J Hepatol; 2006 Jun; 44(6):1150-7. PubMed ID: 16458994
[TBL] [Abstract][Full Text] [Related]
2. Effect of maternal cholestasis on TGR5 expression in human and rat placenta at term.
Keitel V; Spomer L; Marin JJ; Williamson C; Geenes V; Kubitz R; Häussinger D; Macias RI
Placenta; 2013 Sep; 34(9):810-6. PubMed ID: 23849932
[TBL] [Abstract][Full Text] [Related]
3. Role of the bile salt export pump, BSEP, in acquired forms of cholestasis.
Stieger B
Drug Metab Rev; 2010 Aug; 42(3):437-45. PubMed ID: 20028269
[TBL] [Abstract][Full Text] [Related]
4. Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy.
Pauli-Magnus C; Meier PJ; Stieger B
Semin Liver Dis; 2010 May; 30(2):147-59. PubMed ID: 20422497
[TBL] [Abstract][Full Text] [Related]
5. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
Stieger B
Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone-induced intrahepatic cholestasis by an interference with the hepatobiliary export of bile acids in male and female rats. Correlation with the gender difference in troglitazone sulfate formation and the inhibition of the canalicular bile salt export pump (Bsep) by troglitazone and troglitazone sulfate.
Funk C; Pantze M; Jehle L; Ponelle C; Scheuermann G; Lazendic M; Gasser R
Toxicology; 2001 Oct; 167(1):83-98. PubMed ID: 11557132
[TBL] [Abstract][Full Text] [Related]
7. Basal efflux of bile acids contributes to drug-induced bile acid-dependent hepatocyte toxicity in rat sandwich-cultured hepatocytes.
Susukida T; Sekine S; Ogimura E; Aoki S; Oizumi K; Horie T; Ito K
Toxicol In Vitro; 2015 Oct; 29(7):1454-63. PubMed ID: 26055650
[TBL] [Abstract][Full Text] [Related]
8. Progesterone metabolites as farnesoid X receptor inhibitors.
Abu-Hayyeh S; Williamson C
Dig Dis; 2015; 33(3):300-6. PubMed ID: 26045261
[TBL] [Abstract][Full Text] [Related]
9. Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver.
Stieger B; Fattinger K; Madon J; Kullak-Ublick GA; Meier PJ
Gastroenterology; 2000 Feb; 118(2):422-30. PubMed ID: 10648470
[TBL] [Abstract][Full Text] [Related]
10. Disruption of BSEP Function in HepaRG Cells Alters Bile Acid Disposition and Is a Susceptive Factor to Drug-Induced Cholestatic Injury.
Qiu X; Zhang Y; Liu T; Shen H; Xiao Y; Bourner MJ; Pratt JR; Thompson DC; Marathe P; Humphreys WG; Lai Y
Mol Pharm; 2016 Apr; 13(4):1206-16. PubMed ID: 26910619
[TBL] [Abstract][Full Text] [Related]
11. Cholestatic potential of troglitazone as a possible factor contributing to troglitazone-induced hepatotoxicity: in vivo and in vitro interaction at the canalicular bile salt export pump (Bsep) in the rat.
Funk C; Ponelle C; Scheuermann G; Pantze M
Mol Pharmacol; 2001 Mar; 59(3):627-35. PubMed ID: 11179459
[TBL] [Abstract][Full Text] [Related]
12. The endothelin antagonist bosentan inhibits the canalicular bile salt export pump: a potential mechanism for hepatic adverse reactions.
Fattinger K; Funk C; Pantze M; Weber C; Reichen J; Stieger B; Meier PJ
Clin Pharmacol Ther; 2001 Apr; 69(4):223-31. PubMed ID: 11309550
[TBL] [Abstract][Full Text] [Related]
13. BSEP inhibition: in vitro screens to assess cholestatic potential of drugs.
Kis E; Ioja E; Rajnai Z; Jani M; Méhn D; Herédi-Szabó K; Krajcsi P
Toxicol In Vitro; 2012 Dec; 26(8):1294-9. PubMed ID: 22120137
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump.
Rodrigues AD; Lai Y; Cvijic ME; Elkin LL; Zvyaga T; Soars MG
Drug Metab Dispos; 2014 Apr; 42(4):566-74. PubMed ID: 24115749
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Na+-taurocholate Co-transporting polypeptide-mediated bile acid transport by cholestatic sulfated progesterone metabolites.
Abu-Hayyeh S; Martinez-Becerra P; Sheikh Abdul Kadir SH; Selden C; Romero MR; Rees M; Marschall HU; Marin JJ; Williamson C
J Biol Chem; 2010 May; 285(22):16504-12. PubMed ID: 20177056
[TBL] [Abstract][Full Text] [Related]
16. Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2.
Chen H; Huang X; Min J; Li W; Zhang R; Zhao W; Liu C; Yi L; Mi S; Wang N; Wang Q; Zhu C
J Ethnopharmacol; 2016 Feb; 179():197-207. PubMed ID: 26723467
[TBL] [Abstract][Full Text] [Related]
17. Estradiol-17beta-D-glucuronide induces endocytic internalization of Bsep in rats.
Crocenzi FA; Mottino AD; Cao J; Veggi LM; Pozzi EJ; Vore M; Coleman R; Roma MG
Am J Physiol Gastrointest Liver Physiol; 2003 Aug; 285(2):G449-59. PubMed ID: 12702498
[TBL] [Abstract][Full Text] [Related]
18. The bile salt export pump.
Stieger B; Meier Y; Meier PJ
Pflugers Arch; 2007 Feb; 453(5):611-20. PubMed ID: 17051391
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of bile acid transport across Na+/taurocholate cotransporting polypeptide (SLC10A1) and bile salt export pump (ABCB 11)-coexpressing LLC-PK1 cells by cholestasis-inducing drugs.
Mita S; Suzuki H; Akita H; Hayashi H; Onuki R; Hofmann AF; Sugiyama Y
Drug Metab Dispos; 2006 Sep; 34(9):1575-81. PubMed ID: 16760228
[TBL] [Abstract][Full Text] [Related]
20. The bile salt export pump: molecular properties, function and regulation.
Arrese M; Ananthanarayanan M
Pflugers Arch; 2004 Nov; 449(2):123-31. PubMed ID: 15578267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
